Abstract: After G protein-coupled (GPC) receptors, protein kinases are considered as most important drug targets. Kinase family consists of multigene, which is particularly relevant to various diseases. Protein phosphorylation by kinases plays a crucial activity in many cellular processes like apoptosis, cell division, survival, metabolism, etc. The emergence of various protein kinases crystal structures from many research groups gives a deep insight to understand the catalysis and regulation of different protein kinases. This review will mainly focus on the active site structures and functions of few kinases related to different families such as Protein A, G, and C kinase family (AGC), Ca 2+ /Calmodulin-dependent kinase family (CaMK), Cyclin-dependent kinase family (CMGC), Receptor guanylatecyclase family (RGC), Tyrosine kinase family (TK), Tyrosine kinase-like family (TKL), Sterile 20 Serine/threonine kinase family (STE), and Casein kinase 1 family (CK1).
INTRODUCTION
Protein kinases play very important role in the regulation of cells. The phosphorylation and dephosphorylation are very important processes to activate and deactivate the macromolecules. Kinase proteins donate the phosphate group from high energy to specific substrates, phosphorylation, and accept the phosphate group from phosphorylated substrates, dephosphorylation. Till now the regulation of kinases and its substrate selectivity remain unclear [1] . A large variety of the cellular processes are activated by various protein kinases directly by adding the phosphate group to the substrate. The first evidence of the phosphorylation of the protein kinase was observed by Kenndy and Burnett [2] . There are 50 distinct kinase families found in yeast, invertebrates, and mammalian kinomes based on the essential functions.
During the growth and development, the cellular process was regulated by kinases. Approximately, one third of the proteins can be turning on and off in a cellular pathway by the phosphorylation and dephosphorylation activity of kinases [1] . It is well-known that the imbalance in the kinases activity will be a major cause of various diseases. Protein kinases act as key regulators of cell functions and *Address correspondence to these authors at the Division of Applied Life Science, Gyeongsang National University, 501 Jinju-daero, Jinju, 52828 Republic of Korea and Department of Internal Medicine, College of Medicine, Busan Paik Hospital, Inje University, Gimhae, Republic of Korea; Tel: +82-55-752-1360; Fax: +82-55-772-1359; E-mails: kwlee@gnu.ac.kr, and psjgenesis@hanmail.net thus make themselves extremely important drug targets.Based on the catalytic domain sequence similarity in human protein kinases, nearly 478 kinases out of the 518 were found to belong to single superfamily. The pharmaceutical industries mainly target the ATP-binding site, a well conserved binding pocket in the kinase family, for drug development [1] . Identifying the selective kinases inhibitors will be a challenging task for the researchers due to the highly conserved ATP-binding site. This review explains the current details of the structure and function of various protein kinases.
PROTEIN KINASES
For most of phosphorylation reactions involved in cellular processes, kinases are indispensable. The transfer of phosphoryl groups to the substrates or target proteins to alter its function or activity is known as phosphorylation and the reverse process, which removes the phosphoryl group from the substrate or target protein is called dephosphorylation [3] . The phosphorylation is the important mechanism which transfers the intra-and extra-cellular signals in the cell and nucleus. Protein kinases play various important roles in cell growth, differentiation and development and function and death [3] . Various classes of protein kinases were reported, among them two important classes are reported based on the substrate specificity and sequence similarity of catalytic domain. Kinases based on substrate specificity were classified depending on the phosphorylation of the residues in the target proteins and thus there were two important kinases: tyro-sine kinases that phosphorylate Tyr residues and Ser-Thr kinases that phosphorylate Ser or Thr residues. Both have a common catalytic domain consisting of N-terminal ATPbinding pocket and a conserved Asp residue required for their catalytic function [4] . The kinases family was classified into seven main families based on the catalytic domains sequence similarity, namely protein A, G, and C kinase (AGC), Ca 2+ /Calmodulin-dependent kinase (CAMK), Cyclin-dependent kinase (CMGC), Tyrosine kinase (TK), Sterile 20 Serine/threonine kinase (STE), Tyrosine kinase-like family (TKL), and Casein kinase 1 (CK1) [5] . Several highly conserved residues and the homology regions are present in the conserved region of approximately 250 residues responsible for the kinase activity and the structural core. A common tertiary structure of all protein kinases has small aminoand large carboxy-terminus lobes. The co-factor ATP sites snugly in the kinase active site cleft, present between the Nand C-terminus, in such a way that the phosphate groups orient outwards as well as towards the cleft mouth. The substrate binding site presets at the cleft entrance and mainly interacts with the surface of carboxyl-terminal lobe. The surrounding amino acids in the active site transfer the ATP -phosphate to the protein substrate (hydroxyl oxygen in the substrate). The active forms of the kinases are similar to each other but show the difference in inactive conformations between the kinase families [3] .
Due to the high similarity of ATP-binding site in different kinases will become a challenge for the researchers to identify the selective inhibitors of kinases in the active state without affecting the other kinase subclasses. Most of the kinase inhibitors are competitive inhibitors which mimic hydrogen bonds between critical amino acids in the kinase active site and adenine fragment of ATP [6] . Interestingly, there are five distinguished regions present in the ATP, such as adenine region, sugar region, phosphate binding region, hydrophobic pocket, and hydrophobic channel that help to design selective inhibitors of kinases [7] . The hydrophobic adenine region forms two important hydrogen bonds in the adenine anchoring hinge region of protein kinases. One of these hydrogen bonds was present in many protein kinases. The hydrophilic part of ATP binding in most of the protein kinases is sugar region except for the EGFR. The hydrophobic channel present in the N-terminal region is induced by C helix. Although the hydrophobic pocket (or selective pocket) and hydrophobic channel are not used by ATP, but they play a vital role in kinase inhibitor selectivity and binding affinity, respectively. The triphosphate group of ATP binds in the phosphate-binding region consisting of basic residues and glycine-rich region involved in the catalytic process [7] . Changes in the kinase activity can be achieved by several strategies like blocking the ATP binding to inhibit the phosphorylation activity; interrupt the protein-protein interactions and down-regulation of kinase gene expression.
All kinases contain two distinct lobes, structurally and functionally, which contribute in specific ways to control the catalysis and regulation process. The interface between the two lobes is different when compared with most of the kinases. The N-lobe contains 5 -sheet coupled to a helical subdomain consisting of C-helix and C -4 loop is anchored to the C-lobe. The first three b-strands contain two highly conserved motifs: (i) glycine rich loop (GxGXXG) is present between the 1 -2, the most flexible part. In a ternary complex, the tip of N-loop is fully closed when the backbone is anchored to -phosphate of ATP.
TYROSINE KINASES
TK, first identified protein kinases, phosphorylate exclusively on tyrosine, as opposed to most kinases selective for Ser or Thr. The tyrosine kinase group, a large and diverse kinase family, which phosphorylates the tyrosine residues, is involved in the regulation of multicellular aspects of the organism [8] . Tyrosine kinase family is classified into two groups: RTKs and CTKs. The catalytic activity of RTKs is activated by the binding of an extracellular molecule, generally a protein growth factor. CTKs, function in complexes tethered to the plasma membrane, contain SH2 and/or SH3 domains activated by phosphotyrosine. In humans, the tyrosine kinases play a vital role in many diseases like cancer and diabetes. Tyrosine kinase genes have also been linked to a wide variety of congenital syndromes [8] [9] [10] [11] [12] [13] [14] . TKs have highly conserved catalytic domains similar to Ser/Thr protein but its unique subdomain motifs clearly differentiate from other TKs [8, 15] .
TKs have also a bi-lobar structure consisting of N-and C-terminal lobes. The N-terminal lobes consist of b-sheets where the ATP and magnesium can bind. The C-terminal lobe consists of a-helices. These two lobes were connected by flexible regions known as hinge region. Mostly the polypeptide substrates can bind to the cleft formed between the two lobes [16] . The adenosine moiety of ATP binds in the hydrophobic cleft formed between the N-and C-terminal lobes by van der Waals interactions and H-bond interactions to the hinge region [17] .
The non-receptor tyrosine kinases of src family (SFK) are coupled with various growth factor receptors to regulate the various functions such as proliferation and survival and cell adhesion etc [18] [19] [20] . It plays crucial role in controlling the signal transduction in various cellular environments [21] . Out of the eleven Src-related kinases, eight (Blk, Fgr, Fyn, Lck, Lyn, Hck, c-Src, and c-Yes) of them are mainly present in mammalian cells [18] . The activity of c-Src is regulated by tyrosine phosphorylation, SH2 and SH3 domains mediated by protein-protein interactions [21] .
SRC FAMILY KINASES
Src family kinases (SFKs) are one of the non-receptor TKs and classified into nine groups based on the structure and functional similarity such as c-Src, Yes, Fyn, Lyn, Lck, Hck, Fgr, Blk and Yrk. SFKs consist of four Src homology domains 1, 2, 3, and 4 (SH1, SH2, SH3, and SH4) which are depicted in Fig. (1) [22] [23] [24] . The SH1 domain phosphorylates the Tyr residue present in C-terminal. SH2 domain is a selective domain, which recognizes the phosphorylated Tyr residue [22, 25] . This domain is important for Src regulation activity or binding to other Tyr proteins. SH2-linker connects the two domains and regulates its activity by interacting with SH3 domain. SH3 domain mediates the proteinprotein interactions with c-Src itself [22, 25, 26] . The SH4 in N-terminal region contains a myristoylation sequence, which is important for membrane binding. A unique region is lo-cated between SH3 and SH4 domains. The phosphorylation makes Src to be active from inactive form. Though many potent and selective compounds against SFKs are synthesized but still it lacks the information of critical chemical features of c-Src inhibitors.
c-Src plays a vital role in various cellular process like cell adhesion, proliferation, and angiogenesis [22] . The c-Src is a cytoplasmic protein comes under the non-receptor tyrosine kinase family [22, 27] . c-Src plays many roles in cell signaling, transferring the signals by interactions with multiple proteins and its complexes. Human c-Src, Tyr419 and Tyr530 are two major phosphorylation sites ( Fig. 1) [28] . Tyr419 in c-Src can be auto-phosphorylated and activated by displacing the P-Tyr419 from binding pocket which allows the substrate to enter. c-Src activity also regulated by phosphorylation and dephosphorylation of tyrosine (Y530) present in C-terminal various proteins like CSK or SHP-1. The open and close states, active and inactive, of c-Src are mainly dependent on the dephosphorylation and phosphorylation of Y530 states with SH2, respectively. In addition, the protein interaction directly regulates the activation of c-Src by regulating the Src or shifting the Src to the action site. The platelet-derived growth factor and focal adhesion kinase bind to Src-SH2 domain which activated the c-Src [22, 29] . The 3-D structure of c-Src revealed the importance of the structural features responsible for its biological functions [22, 30, 31] . The TK family kinases exhibit a conserved domain such as myristoylated N-and C-terminal segment, SH2, SH3, linker and tyrosine kinase domains [21] . The Src kinases SH2 and SH3 domains elucidated the mechanisms of phosphotyrosine and proline-motif recognitions, respectively. The auto-inhibited Src kinase structures revealed a mode of domain assembly by kinases from outside Src family [21] .
Large conformation changes of Src kinases can occur by changing from active to inactive state vice versa [32] . Overall catalytic domain structures are closely related to other proteins in the kinases family like protein kinase [33, 34] and Csk [35] [36] [37] , and are highly conserved. Like other kinases, it also contains the N-and C-terminal catalytic lobe and the active site is located between the lobes, where the ATP transferred the g-phosphoryl group to the substrate tyrosine residues [38, 39] . The three important differences between the active and inactive kinases are (i) A-loop, central activation-loop, controls the substrate accessibility to the active site, (ii) rotation of C helix, and (iii) orientation between the N-and C-lobes. There are several components that activate the kinase domain, such as the position of the helix C, conformation of A-loop, and configuration of the catalytic domains.
AGC FAMILY OF KINASES
The AGC kinases family includes cAMP-dependent protein kinase (PKA), protein kinase G (PKG), and protein kinase C (PKC). These proteins contain many intracellular signaling kinases which are modulated by cyclic nucleotides, phospholipids and calcium. The AGC kinases are the most evolutionary conserved groups in the kinase families [5] . The AGC kinase group is comprised of 12% of the human kinome present in the human genome where classified into 14 and 21 families and subfamilies, respectively [5] . The 14 families AGC kinases are MAST, RSK, PDK1, PKC, SGK494, PKG, DMPK, PKN/PRK, NDR, PKA, AKT/PKB, YANK, GRK, and SGK. The AGC and Aurora kinases are closely related to each other and share many aspects of the molecular mechanisms of regulation [1] . AGCs are one of the potential drug targets for the treatment of various diseases like cancer, neurological disorders, obesity, diabetes, inflammation and viral infections. The PIF-pocket is the regulatory site where a PKD1 substrate binding pocket is important for AGC activation by phosphorylation.
STRUCTURE AND REGULATION OF AGC KINASES
Like other protein kinases, AGC also shares a conserved N-and C-terminal lobe connected with a hinge region. The catalytic active site is present in the interface of the domains mainly composed of the Gly-rich loop where ATP can bind [40] . The activation loop is another important feature located between the large and C-helix in small lobe. Like other kinases, the substrate binding site is present between the interfaces of the two lobes in an extended conformation [1] . The catalytic domain of AGC kinases varies among different families with sequence identities between 35% and 45%. A unique sequence is present in the C-terminal region which contains a hydrophobic motif to fold back into the catalytic core.
PROTEIN KINASE-A
One of the simplest members of this protein kinase family is cAMP-dependent protein kinase. The major biological processes of protein kinase-A are aging [41] , long termpotentiation of memory formation [42] , tumorigenesis [43] , cell migration [44] , epithelial-mesenchymal transition [45] , and inflammation [46, 47] . Protein kinase-A is a heterotetramer composed of 2 subunits: (i) catalytic subunit and (ii) regulatory subunits ( Fig. 2A) [48] . The catalytic subunit is the active site where the ATP can bind. The regulatory subunit is formed of two molecules to form a homodimer, where the molecules bind to one another in an anti-parallel orientation. cAMP binds to the regulatory subunits so as to release the active catalytic subunits, allowing them to phosphorylate specific substrate protein (Fig. 2B) [48] . The type I subunit has two domains: (i) bind to cAMP, and (ii) "autoinhibitor" domain serves as a pseudosubstrate or substrate for catalytic subunit. The catalytic domain of protein kinase A consists of conserved residues ~250 to 300 amino acids which play an important role in nucleotide and peptide substrate bindings, and phosphoryl transfer. It has a classical kinase fold consisting of N-terminal lobe which contains -sheet adjacent to a single -helix that is associated with ATP binding. The Cterminal lobe serves as a binding site for the substrate and also contains the conserved amino acids directly involved in the phosphate transfer. A short flexible linker connects the two lobes and the ATP can bind to the interface of the two lobes. The substrates bind to the hydrophobic core and help to transfer the ATP -phosphate to its substrate. The four regulatory subunit isoforms control the activity of catalytic subunit. The N-and C-terminal of the regulatory subunit has conserved subdomains like dimerization/docking domain and two cAMP binding domains, respectively. The regulatory subunits play various roles but are not functionally redundant [49] .
CMGC GROUP OF KINASES
The CMGC kinase group of kinases are essential kinase proteins and a large group present in eukaryotes. The CMGC kinases are glycogen synthase kinases (GSKs), cyclindependent kinases (CDKs), CDK-like kinases and mitogenactivated protein kinases (MAPKs). This group of kinases has a diversity of functions in cell cycle control. In eukaryotes, the cyclin-dependent kinases lead these processes by coordinating the sequence. The CDK activity was initiated by the binding of the protein partner in the cyclin family which phosphorylates the conserved Thr residue in CDK. The degradation of cyclin and dephosphoryaltion of the Tyr residues in the CDK deactivate its function [50] . The cyclicdependent kinases, family of serine/threonine protein kinases, are composed of little more than the catalytic core shared by all protein kinases. The CDK enzymes play an important role in cell cycle by phosphorylating many proteins that are involved in other cellular processes [51] . Mostly, CDKs target the other highly favorable residues that are Thr or Ser followed by Pro, which have a basic residue two positions after the target residue. The CDKs typical phosphorylation sequence are [S/T*]PX[K/R], where S/T* -phosphorylated serine or threonine, X -any amino acid, and K/R -basic amino acids like lysine (K) or arginine (R) [52] . They are only active in complexes with regulatory subunits called cyclins. CDKs can be activated either by the phosphorylation of other kinases or through their association with cyclins [53] . Hence, active CDKs are mainly by catalytic and regulatory subunits [54] . The level of cyclin, a cell, plays an important role in the activation of CDK. The rising and falling levels of cyclin help to form a stable active CDKs heterodimeric complexes and lose the catalytic activity to phosphorylate their substrates, respectively [53] . In a certain period of cell cycle, few cyclin proteins bind with the CDK and forms cyclin-CDK complex that shows the highest kinase activity.
The crystallographic studies revealed the structural insight of Homo sapiens CDK2. The T-loop or activation loop, large flexible loop present in the C-terminal present in the active site entrance and block the substrate binding. Due to this, the phosphates atom in ATP is not properly oriented for kinase reaction. Extensive structural changes in the active site are required to activate the CDK (Fig. 3) [55, 56] . In particular, the two helices are crucial to control the CDK activity. The conserved PSTAIRE helix present in the upper region of kinase lobe that directly interacts with cyclin which moves the conserved helix inward. This helix movement helps to reorient the residues interacting with the phosphate of ATP. The L12 helix present before the T-loop which changed to a -strand due to the cyclin binding and reconfigures the active site and T-loop. In the activated CDK2, an intermolecular hydrogen bond was observed between the ATP and Thr14, which is an inhibitory phosphorylation site.
GSK3 is an important enzyme, which is involved in the glycogen metabolism and regulates various functions. GSK3, well-studied enzyme in Wnt pathway, is essential for establishing the entire body pattern during the embryonic development. The substrate specificity of GSK3 is different from other kinases, to efficiently phosphorylate the protein substrates, which requires the additional residue to phosphory-late, mostly located at the C-terminal site of GSK3 phosphorylation.
CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE (CAMK)
CaMK 2 is a calcium dependent kinase whose activity is extremely low in its basal state. The initial activation of CaMK family mainly depends on the Ca 2+ /CaM binding but some of the kinases are activated independently or require additional phosphorylation to complete its activation [57] . The consensus sequence in CaM-kinase substrates (Arg-X-X-Ser/Thr) is used to predict the important phosphoryalation sites in the proteins [57] [58] [59] . The 2 isoforms of CaMK are expressed as a monomer: (i) 505 residues in isoform and (ii) a 587 residues are composed to form a larger isoform. Both the isoforms have shown a unique difference in their mechanism of regulation. The domain structure of CaMK has two globular domains (bi-lobed) connected by a linker to form an auto inhibitory cleft and CaM-binding domain by extending the sequence from N-to C-terminus [60] . CaMK occupies the cytosol as well as the nucleus and responds to the Ca 2+ concentration changes in both. The autoinhibitory domain present in CaMK interacts with catalytic domain to stabilize its inactive state and prevents the kinase activity. The CaMK was activated by the Ca 2+ /CaM binding which helped to expose the catalytic site by displacing the autoinhibitory domain and subsequently phosphorylate its downstream substrates. There are two distinct catalytic CaMK domains, one that lacks conserved acidic residues which normally recognize basic residues in protein substrates and other Arg-Pro rich domain that is important for the recognition of CaMK-I and CaMK-IV substrates [61] . Deletion of Arg-Pro rich domain inhibits the ability of CaMK-I and CaMK-IV to phosphorylate [62] .
CaMK-II, one of the highly interested kinase family proteins, has 4 isoforms namely , , and [63] . The and isoforms are brain specific [64] and and are expressed in the rest of the body [65] . All the 4 isoforms of CAMK-II have shown a similar N-terminal domain like other CaMKs and in addition there is an associated C-terminal domain which is required for the assembly of CaMK-II apo into a 12 subunit complex [63] . In 2000 and 2005, the active [66] and inactive [67] forms of CaMK-II were resolved. The active crystal structure revealed that CaMK-II expressed as a dodecameric structure. Each monomer contains four functional domains with N-terminal kinase domain (catalytic domain), CaM-binding regulatory domain, followed by a variable linker domain, and a C-terminal association domain. T253, T286, T305, T306, and S341 are important phosphorylation sites (Fig. 4) [68, 69] . C terminal association domain directs assembly of the CaMK-II multimeric structure. N-terminal kinase domain is the catalytic domain, a binding site to potential substrates. Regulatory domain can bind to the catalytic domain as a substrate within each monomer. Linker domain can help to adjust regulatory domain within multimer to block both substrate and ATP binding to the catalytic domain itself. The barrel-shaped core, formed by the association of the multi-subunit domains, with 6 catalytic domains radially extends from both ends of the core. In the inactive auto-inhibited catalytic domain of CaMK-II, a prototypical kinase catalytic core was revealed. Surprisingly, the crystal structure revealed that there were two auto-inhibitory domains, formed by coiled-coil in a dimeric complex, which blocks the ATP-and substrate-binding lobe of the catalytic domains.
CONCLUDING REMARKS
In this review, we have briefly described the structures and functions of few kinases. Our examination gives a deep insight to understand catalysis and regulation of different protein kinases, which will facilitate future protein kinasebased drug design. This review discussed four different protein kinases including c-Src, PKA, CDK2, and CaMK-II. They have shown a unique difference in their mechanism of regulation. c-Src is one of the non-receptor tyrosine kinases, which contains four major domains, SH4, SH3, SH2, SH1. It acts by suppressing the activity by phosphorylation at conserved C-terminal tail site and is engaged in intramolecular interactions between the phosphorylation tail and SH2 domain. Human Src has two phosphorylation sites. One is autophosphorylated at Tyr419 and other is Tyr530, which can be activated and deactivated by many proteins.
The protein kinase A is a cAMP-dependent enzyme containing a regulatory dimer and two catalytic subunits. It gets activated only when 4 molecules of cAMP bind to regulatory dimer, two to each monomer. Cyclin-dependent kinase is another family kinase related to cell cycle. The structure details of human CDK2 revealed that the two changes to make them inactive in absence of cyclin: (i) T-loop, activation loop which blocks the entrance of the substrate protein to bind in the active site cleft and (ii) many key residues are incorrectly positioned in the active, so that the phopsphates of ATP cannot interact with CDK. Hence, to activate the CDK, it requires structural changes in active site such as PATAIRE helix and L12 helix.
The initial stimulation of Calcium/calmodulin-dependent kinase is mainly dependent on Ca 2+ /CaM. CaMK-II is one of the highly interesting CaM-kinase proteins due to its particularly elegant relationship between the structure and function. CaMK-II is expressed as a dodecamer. Each monomer has four functional domains containing C-terminal association domain, variable linker domain, regulatory domain, and Nterminal catalytic domain. Individual monomers assemble into a dodecamer through association at C-terminal domain of each subunit. N-terminal catalytic domain can bind to the substrates and perform the serine/threonine kinase function. The intervening regulatory domain connects N-and Cterminal domains.
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